Bank of America’s Argos Therapeutics, Inc. ARGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-293
Closed 7641
2018
Q1
$0 Buy
+293
New +$549 ﹤0.01% 7617
2017
Q4
Sell
-38
Closed 7565
2017
Q3
$0 Sell
38
-277
-88% -$1.33K ﹤0.01% 7577
2017
Q2
$2K Sell
315
-128
-29% -$1.09K ﹤0.01% 6784
2017
Q1
$4K Buy
443
+288
+186% +$18.2K ﹤0.01% 6728
2016
Q4
$16K Buy
155
+41
+36% +$3.84K ﹤0.01% 6436
2016
Q3
$11K Buy
114
+98
+613% +$10.2K ﹤0.01% 6373
2016
Q2
$2K Buy
+16
New +$2.14K ﹤0.01% 6965
2016
Q1
Sell
-15
Closed -$1K 7793
2015
Q4
$1K Hold
15
﹤0.01% 7262
2015
Q3
$1K Buy
+15
New +$1.78K ﹤0.01% 7144
2014
Q4
Sell
-100
Closed -$20K 8452
2014
Q3
$20K Sell
100
-734
-88% -$115K ﹤0.01% 7062
2014
Q2
$134K Buy
+834
New +$138K ﹤0.01% 5897

Other funds holding ARGS

Bank of America's ARGS Position: Q2 2018 in Review

Bank of America sold out of Argos Therapeutics, Inc. (ARGS) in Q2 2018, closing a stake of 293 shares.

Bank of America first reported a position in ARGS in Q2 2014 and held it in 11 quarters. The position peaked at $134K in Q2 2014. 4 funds tracked by Wall St. Rank hold ARGS as of Q2 2018.

  • Bank of America reported no remaining Argos Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Bank of America sold 293 Argos Therapeutics, Inc. shares in Q2 2018.
  • Bank of America first reported a position in Argos Therapeutics, Inc. in Q2 2014 and held it in 11 quarters.
  • Bank of America's Argos Therapeutics, Inc. position peaked at $134K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q2 2018.

Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.